Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medical therapy for SLE.

D B Hellmann1

  • 1Johns Hopkins University School of Medicine, Baltimore, MD.

Maryland Medical Journal (Baltimore, Md. : 1985)
|October 1, 1991
PubMed
Summary

Corticosteroids are crucial for treating systemic lupus erythematosus but cause significant side effects. Research aims to maintain treatment benefits while minimizing adverse reactions in lupus patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions.

Arthritis care and research : the official journal of the Arthritis Health Professions Association·2003
Same author

Vasculitis. A collection of pearls and myths.

Rheumatic diseases clinics of North America·2001
Same author

Treatment of Wegener's granulomatosis.

Rheumatic diseases clinics of North America·2001
Same author

Three-dimensional volume-rendering CT angiography in vasculitis: spectrum of disease and clinical utility.

Journal of computer assisted tomography·2001
Same author

Reliability of normal findings on MR imaging for excluding the diagnosis of vasculitis of the central nervous system.

AJR. American journal of roentgenology·2001
Same author

Large artery vasculitis following recombinant hepatitis B vaccination: 2 cases.

The Journal of rheumatology·2001

Area of Science:

  • Rheumatology
  • Immunology
  • Pharmacology

Background:

  • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease.
  • Corticosteroids are a cornerstone of SLE treatment, effectively managing inflammation and disease activity.
  • However, long-term corticosteroid use is associated with numerous debilitating side effects, posing a major therapeutic challenge.

Purpose of the Study:

  • To explore strategies for preserving the therapeutic efficacy of corticosteroids in SLE.
  • To identify methods for mitigating the adverse effects associated with corticosteroid therapy in lupus patients.
  • To advance the management of systemic lupus erythematosus by optimizing treatment regimens.

Main Methods:

  • Review of current clinical practices and treatment guidelines for SLE.
  • Analysis of pharmacological data on corticosteroid mechanisms and side effect profiles.
  • Exploration of emerging therapeutic approaches and supportive care strategies.

Main Results:

  • Corticosteroids remain essential for achieving disease control in many SLE patients.
  • Significant toxicities limit the long-term use and optimal dosing of corticosteroids.
  • The need for steroid-sparing agents and personalized treatment plans is evident.

Conclusions:

  • Balancing the benefits and risks of corticosteroids is critical in SLE management.
  • Further research is needed to develop safer and more effective treatment paradigms for systemic lupus erythematosus.
  • Minimizing corticosteroid exposure while maintaining disease remission is a key objective for improving patient outcomes.

Related Experiment Videos